Silver Ronald's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Aug 14, 2024
- Accession no.
- 0000950170-24-097182
- Filed
- Aug 14, 2024
- Trade date
- Aug 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $13.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silver RonaldCIK 0001873731 | Officer (Principal Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Class A Common Stock | SSaleDisposed | −3,107 | $4.27 | −$13,266.89 | 158,370 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.